MedTrace Logo

Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member

NCT04649944 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-12-22

No results posted yet for this study

Summary

Use of rapid serological tests to assess the vulnerability to SARS-CoV-2 infection of subjects aged 4-16 years old and cohabiting with at least one family member who tested positive to SARS-CoV-2

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Serological test and phone interview

Families are interviewed by telephone to gather information about the family cluster (i.e. age and number of cohabitants, their symptoms and swab results, if performed), the subject who tested positive (i.e.sex, age, course of the disease, symptoms suggestive of COVID-19) and children aged between 4 and 16 y.o. (i.e. sex, age, drug therapy and/or chronic diseases, symptoms suggestive of COVID-19). Children, young adults and the cohabitant who previously tested positive to the swab undergo a serological test for the detection of IgG and IgM antibodies for Sars-Cov-2.

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Principal Investigators

  • Giampietro Farronato, DDS · University of Milan

Eligibility

Min Age
4 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-05
Primary Completion
2021-11-01
Completion
2021-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04649944 on ClinicalTrials.gov